Literature DB >> 12088337

Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery.

M Lindberg1, A Hole, H Johnsen, A Asberg, A Rydning, H E Myrvold, K S Bjerve.   

Abstract

Procalcitonin (PCT). a new marker proposed as a diagnostic tool for bacterial infections, triggers a systemic-inflammatory reaction in the body (sepsis, septic shock) and has potential use in a wide range of patient settings. To interpret the results from PCT measurements, we depend on reference intervals established from relevant populations. PCT and C-reactive protein (CRP) concentrations were analysed in 47 patients with a normal postoperative course after major abdominal surgery. The mean concentration of PCT declines from the first day and reaches half its initial values on the second day after the operation. whereas the mean concentration of CRP increases in the first 48 h and reaches half its maximum value on the fifth day after the operation. We present a continuous reference interval for plasma PCT and CRP concentrations in the first week following major abdominal surgery. For PCT we also present a graphic display of expected mean and expected upper reference limits predicted from the value measured on the first postoperative day.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12088337     DOI: 10.1080/003655102317475443

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  19 in total

Review 1.  Procalcitonin: present and future.

Authors:  H H Liu; J B Guo; Y Geng; L Su
Journal:  Ir J Med Sci       Date:  2015-07-10       Impact factor: 1.568

2.  Effects of volumetric vs. pressure-guided fluid therapy on postoperative inflammatory response: a prospective, randomized clinical trial.

Authors:  Tamas Szakmany; Ildiko Toth; Zsolt Kovacs; Tamas Leiner; Andras Mikor; Tamas Koszegi; Zsolt Molnar
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

3.  Identification of patients at risk for development of tertiary peritonitis on a surgical intensive care unit.

Authors:  Ansgar M Chromik; Andreas Meiser; Janine Hölling; Dominique Sülberg; Adrien Daigeler; Kirsten Meurer; Heike Vogelsang; Matthias H Seelig; Waldemar Uhl
Journal:  J Gastrointest Surg       Date:  2009-04-08       Impact factor: 3.452

Review 4.  Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis.

Authors:  B Rau; C M Krüger; M K Schilling
Journal:  Langenbecks Arch Surg       Date:  2004-03-06       Impact factor: 3.445

5.  Clinical utility of peri-operative C-reactive protein testing in general surgery.

Authors:  Duncan S Cole; Andrew Watts; David Scott-Coombes; Tony Avades
Journal:  Ann R Coll Surg Engl       Date:  2008-05       Impact factor: 1.891

Review 6.  [Complications after osteosynthetic treatment of acetabular fractures].

Authors:  P Schwabe; F Wichlas; C Druschel; C Jacobs; N P Haas; K-D Schaser; S Märdian
Journal:  Orthopade       Date:  2014-01       Impact factor: 1.087

7.  Comparison of C-reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery.

Authors:  Dagmar Oberhofer; Josip Juras; Ana Marija Pavicić; Iva Rancić Zurić; Vlatko Rumenjak
Journal:  Croat Med J       Date:  2012-12       Impact factor: 1.351

8.  Disease-associated reference intervals for twenty laboratory tests in patients with rheumatoid arthritis, Crohn's disease or ulcerative colitis.

Authors:  Gustav Mikkelsen; Børge Lillebo; Arild Faxvaag
Journal:  Pract Lab Med       Date:  2021-04-17

9.  The usefulness of procalcitonin in the diagnosis of appendicitis in children: a pilot study.

Authors:  Abu N G A Khan; Abdel Sawan; Antonios Likourezos; Mark Schnellinger; Estavan Garcia
Journal:  Emerg Med Int       Date:  2012-12-05       Impact factor: 1.112

10.  The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients.

Authors:  Jens-Ulrik Jensen; Bettina Lundgren; Lars Hein; Thomas Mohr; Pernille L Petersen; Lasse H Andersen; Anne O Lauritsen; Sine Hougaard; Teit Mantoni; Bonnie Bømler; Klaus J Thornberg; Katrin Thormar; Jesper Løken; Morten Steensen; Peder Carl; J Asger Petersen; Hamid Tousi; Peter Søe-Jensen; Morten Bestle; Søren Hestad; Mads H Andersen; Paul Fjeldborg; Kim M Larsen; Charlotte Rossau; Carsten B Thomsen; Christian Ostergaard; Jesper Kjaer; Jesper Grarup; Jens D Lundgren
Journal:  BMC Infect Dis       Date:  2008-07-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.